Moderna
Tracked across 21 events · 1881 articles · First seen May 20, 2025 · Last active Jun 11, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Regulatory
Impact: Moderna had $766 million in funding for its mRNA-1018 vaccine canceled by the United States — United States Department of Health and Human Services, adding uncertainty to the vaccine's development.
May 29, 2025 · 6 articles
Tech
Global health organizations are accelerating efforts to develop vaccines against the Ebola Bundibugyo strain, which is causing an outbreak in Democratic Republic of the Congo and Uganda. The Coalition for Epidemic Preparedness Innovations (CEPI) has…
Impact: Moderna received up to $50 million from CEPI to support the preclinical and early clinical development of its mRNA-based Ebola Bundibugyo vaccine candidate, leveraging its mRNA platform for rapid response.
May 22, 2026 · 36 articles
Tech
The University of Oxford and pharmaceutical firm Moderna>>> have developed a pioneering mRNA vaccine, mRNA-4194, aimed at preventing bowel and ovarian cancers in individuals with Hereditary nonpolyposis colorectal cancer>>>. A clinical trial, named Intercept-Lynch, is…
Impact: Moderna>>> developed the mRNA-4194 vaccine using its mRNA technology, marking its first venture into cancer prevention, which could significantly expand its market and revenue streams.
Jun 08, 2026 · 6 articles
Tech
A new study led by NYU Langone Health has shown that a combination therapy of the personalized mRNA vaccine intismeran (manufactured by Moderna>>>) and the immunotherapy drug pembrolizumab (Keytruda, manufactured by Merck & Co.>>>) significantly…
Impact: As the manufacturer of intismeran, Moderna>>> is a key beneficiary of the positive clinical trial results, which could lead to increased revenue and market share in cancer treatment. The success of intismeran validates Moderna>>>'s mRNA vaccine platform for oncology applications.
Jun 01, 2026 · 6 articles
Accidents
A new Ebola outbreak, caused by the Bundibugyo strain, has emerged in the Democratic Republic of the Congo, primarily in Democratic Republic of the Congo — Ituri Province. The outbreak has resulted in over 220…
Impact: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
International
A severe Ebola outbreak, caused by the rare Bundibugyo strain, is rapidly spreading in the Democratic Republic of the Congo, primarily in Democratic Republic of the Congo — Ituri Province, with cases also confirmed in…
Impact: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.
May 21, 2026 · 627 articles
Accidents
Impact: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.
May 18, 2026 · 505 articles
Business
The Asian Safety and Security Online Exhibition 2026>>> (ASSOE 2026) officially opened on June 1, 2026, and will run for five months until October 31, 2026. Organized jointly by Asianet>>> and TradeAsia>>>, this online exhibition…
Impact: Moderna>>> is a participating supplier in the Asian Safety and Security Online Exhibition 2026>>> (ASSOE 2026), gaining international exposure and sourcing opportunities.
Jun 01, 2026 · 7 articles
Business
A new report by the National Foundation for American Policy reveals that immigrants have founded or co-founded 59% of America's 775 privately held unicorn companies, collectively valued at $5 trillion. India leads with 96 immigrant…
Impact: Moderna is an immigrant-founded unicorn company that has gone public since 2016.
Jun 04, 2026 · 6 articles
Accidents
India — Chhattisgarh Health Minister Shyam Bihari Jaiswal announced that India — Chhattisgarh is fully prepared for a potential Ebola virus outbreak, with three returnees from African countries quarantined in Durga. The India — India…
Impact: Moderna is one of the groups receiving funding to develop an Ebola vaccine, indicating potential future market opportunities.
Jun 04, 2026 · 12 articles
Regulatory
Impact: Moderna, a manufacturer of widely used COVID-19 vaccines, did not immediately comment on the new policy.
May 20, 2025 · 12 articles
Tech
Impact: Moderna is mentioned in the context of a potential combination therapy with Immatics' anzu-cel, indicating future collaborative possibilities in PRAME-directed treatments.
Apr 17, 2026 · 7 articles
95
Moderna expanded collaboration Coalition for Epidemic Preparedness InnovationsCEPI Funds Ebola...
86
Coalition for Epidemic Preparedness Innovations committed funding ModernaCEPI Funds Ebola...
85
Moderna developed vaccine candidateDRC Ebola Outbreak...
85
Moderna developed vaccineOxford, Moderna develop...
85
Coalition for Epidemic Preparedness Innovations committed funding Moderna
85
Coalition for Epidemic Preparedness Innovations committed funding ModernaDRC Ebola Outbreak...
30
Moderna received fundingIndia Prepares for Ebola Outbreak
Vinay Prasad
regulator
↔
Moderna
As a senior FDA official, Vinay Prasad was involved in regulatory decisions rega
+ 72 more relationships
View on Dashboard
NEWSDESK
Track Moderna live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard